Biotech

All Articles

ArsenalBio increases $325M, pivots away from previous lead property

.Arsenal Biosciences is going on up. The cell therapy firm has actually added on $325 million in amm...

Lilly- supported weight-loss biotech reports IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually fil...

Aelis' cannabis make use of drug flunks phase 2b, driving Indivior to review $100M option

.Aelis Farma's hopes of safeguarding a fast, positive decision on a $one hundred thousand choice set...

ProKidney standstills period 3 test certainly not required for tissue therapy approval

.ProKidney has stopped among a pair of stage 3 trials for its own tissue treatment for renal illness...

Vaxcyte climbs on 'remarkable' 31-valent PCV win against Pfizer

.Vaxcyte introduced what experts named "magnificent" stage 1/2 records for its own 31-valent pneumoc...

Recursion's brain disease trial shows insufficient evidence of efficacy

.Recursion has actually discovered via a very early examination of its own tech-enabled method to me...

Acepodia, Pfizer click on together for chemistry-based tissue treatment

.Phone it an instance of really good chemistry: Acepodia, a biotech based upon Nobel Prize-winning s...

Praxis epilepsy drug reduces confiscations in phase 2 trial

.Practice Precision Medicines has actually scored another midphase gain in epilepsy this year, with ...

Three officers surrender as Dyne messages mixed information for DMD candidate

.After escaping a medical hold many years back, Dyne Rehab has disclosed brand new period 1/2 data f...

Arrowhead fires off period 3 records in uncommon metabolic health condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its give in front of a possible showdown with Ionis, p...